Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-25 @ 4:04 AM
NCT ID:
NCT05898802
Eligibility Criteria:
Inclusion Criteria:
* Willing to consent to study participation and to comply with study requirements
* Male and female subjects, 20-65 years of age
* BMI of 23-30 kg/m2
* Those who agreed not to consume Kimchi during the clinical study
Exclusion Criteria:
* Patients with crucial cerebrovascular disease (cerebral infarction, cerebral hemorrhage etc.), or heart failure (angina pectoris, myocardial infarction, heart failure, arrhythmia etc.) or malignancy within 6 months
* Uncontrolled hypertension (Elevated blood pressure (\>160/\>100))
* Thyroid function test abnormality
* Patients with significantly impaired kidney function: serume creatinine levels ≥2 times upper limit of normal
* Patients with significantly impaired liver function: ALT or AST≥3 times upper limit of normal
* Irregular or occasional gastrointestinal disorders (heartburn, indigestion, etc.)
* Having taken drugs with a known influence on weight in the previous 1 month, such as diet pills, anti-depression drugs, beta-blockers, diuretic, contraceptives, corticosteroids, or female hormones
* Participation in other dietary programmes or services within 3 months
* Participation in other clinical trials within the past 1 month
* Alcohol abuse
* Quitted smoking within 3 months
* Pregnancy or lactation or planning on becoming pregnant
* Have a Kimchi allergy
* Those who are judged unsuitable by the researcher for other reasons
* Taking probiotics within 2 weeks
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
65 Years
Study:
NCT05898802
Study Brief:
Protocol Section:
NCT05898802